Enzalutamide is used to treat advanced prostate cancer, especially metastatic resistant prostate cancer. It is an androgen receptor inhibitor, which means it works by blocking the effects of androgens (male hormones) on prostate cancer cells.

XTANDI, the brand name of enzalutamide, contains 40 mg of each active ingredient. It is used as a prostate cancer treatment in unresectable prostate cancer patients, meaning their cancer has progressed to reduced testosterone levels despite medical or surgical treatment

In clinical trials, enzalutamide has been shown to improve metastasis-free survival and overall survival in patients with prostate cancer. It’s also approved for the treatment of castration-sensitive non-metastatic prostate cancer, which means it responds to treatments that lower testosterone levels.

https://www.chawlamedicos.com/anticancer/enzalutamide-40-mg-tablets